lutetium (177 Lu) chloride

This medicine is authorised for use in the European Union.


EndolucinBeta contains the radioactive compound lutetium (177Lu) chloride and is used for radiolabelling other medicines. Radiolabelling is a technique for tagging (or labelling) medicines with radioactive compounds so they can carry radioactivity to where it is needed in the body, for example the site of a tumour.

EndolucinBeta isl to be used to radiolabel medicines that have been specifically developed for use with lutetium (177Lu) chloride.

This EPAR was last updated on 16/02/2021

Authorisation details

Product details
Agency product number
Active substance
lutetium (177Lu) chloride
International non-proprietary name (INN) or common name
lutetium (177 Lu) chloride
Therapeutic area (MeSH)
Radionuclide Imaging
Anatomical therapeutic chemical (ATC) code
Publication details
Marketing-authorisation holder
ITM Medical Isotopes GmbH
Date of issue of marketing authorisation valid throughout the European Union
Contact address

Lichtenbergstrasse 1, Garching b.
Muenchen, Bayern, 85748

Product information

08/02/2021 EndolucinBeta - EMEA/H/C/003999 - R/0019

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Therapeutic radiopharmaceuticals

Therapeutic indication

EndolucinBeta is a radiopharmaceutical precursor, and it is not intended for direct use in patients. It is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with Lutetium (177Lu) chloride.

Assessment history

Changes since initial authorisation of medicine

How useful was this page?

Add your rating
1 rating